Sodium transport antagonism reduces thrombotic microangiopathy in stroke-prone spontaneously hypertensive rats

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 6 55-6, 2004, Pages

  Sepehrdad, Reza ^a   Chander, Praveen N ^a   Singh, Gagan ^a   Stier, Charles T ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Hypertension; Proteinuria; Renal microangiopathy; Stroke prone rats

Indexed keywords

5 (N,N DIMETHYL)AMILORIDE; AMILORIDE; BENZAMIL; DRUG VEHICLE; POTASSIUM; PROTEIN; SODIUM CHANNEL; WATER;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIURESIS; DRUG RESEARCH; DRUG SCREENING; KIDNEY BLOOD VESSEL; NONHUMAN; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PROTON SODIUM EXCHANGE; RAT; RENOVASCULAR DISEASE; SODIUM EXCRETION; SODIUM TRANSPORT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; THROMBOTIC THROMBOCYTOPENIC PURPURA; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION; URINE VOLUME;

EID: 2442661532     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00355.2003     Document Type: Article

References (44)

1. Alzamora R, Michea L, and Marusic ET. Role of 11-β-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 35: 1099-1104, 2000.
2. Benos DJ. Amiloride: a molecular probe of sodium transport in tissues and cells. Am J Physiol Cell Physiol 242: C131-C145, 1982.
3. Benos DJ, Mandel LJ, and Balaban RS. On the mechanism of the amiloride-sodium entry site interaction in anuran skin epithelia. J Gen Physiol 73: 307-326, 1979.
4. Benos DJ and Stanton BA. Functional domains within the degenerin/epithelial sodium channel (Deg/ENaC) superfamily of ion channels. J Physiol 520: 631-644, 1999.
5. Bhargava A, Fullerton MJ, Myles K, Purdy TM, Funder JW, Pearce D, and Cole TJ. The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. Endocrinology 142: 1587-1594, 2001.
6. Camargo MJF, von Lutterotti N, Campbell WG Jr, Pecker MS, James GD, Timmermans PB, and Laragh JH. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. J Hypertens 11: 31-40, 1993.
7. + channel is made of three homologous subunits. Nature 367: 463-467, 1994.
8. + channels are activated by laminar shear stress. J Biol Chem 279: 4120-4126, 2004.
9. Chander PN, Rocha R, Ranaudo J, Singh G, Zuckerman A, and Stier CT Jr. Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP. J Am Soc Nephrol 14: 1990-1997, 2003.
10. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, and Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 96: 2514-2519, 1999.
11. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, and Wehling M. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension 25: 117-125, 1995.
12. +-exchange inhibition by cariporide (Hoe 642): a new principle in cardiovascular medicine. Cardiovasc Drug Rev 17: 134-146, 1999.
13. Drummond HA, Gebremedhin D, and Harder DR. DEG/ENaC proteins: components of a vascular mechanosensor (Abstract). Hypertension 42: 390, 2003.
14. Garty H and Palmer LG. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 77: 359-396, 1997.
15. Golestaneh N, Klein C, Valamanesh F, Suarez G, Agarwal MK, and Mirshahi M. Mineralocorticoid receptor-mediated signaling regulates the ion gated sodium channel in vascular endothelial cells and requires an intact cytoskeleton. Biochem Biophys Res Commun 280: 1300-1306, 2001.
16. Gomez-Sanchez EP and Gomez-Sanchez CE. Effect of central amiloride infusion on mineralocorticoid hypertension. Am J Physiol Endocrinol Metab 267: E754-E758, 1994.
17. Gomez-Sanchez EP and Gomez-Sanchez CE. Effect of central infusion of benzamil on Dahl S rat hypertension. Am J Physiol Heart Circ Physiol 269: H1044-H1047, 1995.
18. + channel. J Biol Chem 272: 21075-21083, 1997.
19. Kau ST, Pritchard WJ, and Leszczynska K. Defect of the potassium transport process in the kidney of spontaneously hypertensive rats. Pharmacology 45: 34-40, 1992.
20. Kleyman TR and Cragoe EJ Jr. Amiloride and its analogs as tools in the study of ion transport. J Membr Biol 105: 1-21, 1988.
21. + channels. Steroids 60: 114-119, 1995.
22. Masilamani S, Kim GH, Mitchell C, Wade JB, and Knepper MA. Aldosterone-mediated regulation of ENaC α, β, and γ subunit proteins in rat kidney. J Clin Invest 104: R19-R23, 1999.
23. Nagaoka A, Iwatsuka H, Suzuoki Z, and Okamoto K. Genetic predisposition to stroke in spontaneously hypertensive rats. Am J Physiol 230: 1354-1359, 1976.
24. Nagashima A, Okuda S, Tamaki K, and Fujishima M. Influence of a high salt diet on glomerular injury and the preventive effects of amiloride in adriamycin nephropathy. Nephron 71: 87-94, 1995.
25. + channels. J Biol Chem 274: 16973-16978, 1999.
26. Nielsen J, Kwon TH, Masilamani S, Beutler K, Hager H, Nielsen S, and Knepper MA. Sodium transporter abundance profiling in kidney: effect of spironolactone. Am J Physiol Renal Physiol 283: F923-F933, 2002.
27. Okamoto K, Yamori Y, and Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res 34: I-143-I-153, 1974.
28. Pearce D. The role of SGK1 in hormone-regulated sodium transport. Trends Endocrinol Metab 12: 341-347, 2001.
29. Pratt JH, Eckert GJ, Newman S, and Ambrosius WT. Blood pressure responses to small doses of amiloride and spironolactone in normotensive subjects. Hypertension 38: 1124-1129, 2001.
30. Rocha R, Chander PN, Khanna K, Zuckerman A, and Stier CT Jr. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 31: 451-458, 1998.
31. Rocha R and Stier CT Jr. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 12: 308-314, 2001.
32. Ruggenenti P and Remuzzi G. Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy. Am J Kidney Dis 27: 459-475, 1996.
33. + channels in the cortical collecting duct by AVP and mineralocorticoids. Kidney Int 41: 255-268, 1992.
34. Sepehrdad R, Chander PN, Oruene A, Rosenfeld L, Levine S, and Stier CT Jr. Amiloride reduces stroke and renal injury in stroke-prone hypertensive rats. Am J Hypertens 16: 312-318, 2003.
35. + homeostasis and hypertension. Endocr Rev 23: 258-275, 2002.
36. Stier CT Jr, Adler LA, Levine S, and Chander PN. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens 11, Suppl 3: S37-S42, 1993.
37. Stier CT Jr, Benter IF, Ahmad S, Zuo H, Selig N, Roethel S, Levine S, and Itskovitz HD. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 13: 115-121, 1989.
38. Stier CT Jr, Chander PN, Gutstein WH, Levine S, and Itskovitz HD. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens 4: 680-687, 1991.
39. Stier CT Jr, Mahboubi K, DiPippo VA, Levine S, and Chander PN. The antiproteinuric action of enalapril in stroke-prone spontaneously hypertensive rats is unrelated to alterations in urinary prostaglandins. J Pharmacol Exp Ther 260: 1410-1415, 1992.
40. Ugawa S, Ueda T, Ishida Y, Nishigaki M, Shibata Y, and Shimada S. Amiloride-blockable acid-sensing ion channels are leading acid sensors expressed in human nociceptors. J Clin Invest 110: 1185-1190, 2002.
41. Vandorpe DH, Ciampolillo F, Green RB, and Stanton BA. Cyclic nucleotide-gated cation channels mediate sodium absorption by IMCD (mlMCD-K2) cells. Am J Physiol Cell Physiol 272: C901-C910, 1997.
42. Vigne P, Champigny G, Marsault R, Barbry P, Frelin C, and Lazdunski M. A new type of amiloride-sensitive cationic channel in endothelial cells of brain microvessels. J Biol Chem 264: 7663-7668, 1989.
43. Wehling M. Nongenonic aldosterone effects: the cell membrane as a specific target of mineralocorticoid action. Steroids 60: 153-156, 1995.
44. Yamori Y, Horie R, Tanase H, Fujiwara K, Nara Y, and Lovenberg W. Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats. Hypertension 6: 49-53, 1984.